tiprankstipranks
PharmAla Biotech Holdings, Inc. (TSE:MDMA)
:MDMA
Canadian Market
MDMA
PharmAla Biotech Holdings, Inc.
RESEARCH TOOLSreports
Want to see TSE:MDMA full AI Analyst Report?

PharmAla Biotech Holdings, Inc. (MDMA) Income Statement

64 Followers

PharmAla Biotech Holdings, Inc. Income Statement

Last quarter (Q2 2026), PharmAla Biotech Holdings, Inc.'s total revenue was C$280.58K, an increase of 92.63% from the same quarter last year. In Q2, PharmAla Biotech Holdings, Inc.'s net income was C$-337.70K. See PharmAla Biotech Holdings, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Nov 25Nov 24Nov 23Nov 22Aug 21
Total Revenue
C$ 605.50KC$ 1.04MC$ 532.00KC$ 78.07KC$ 0.00
Gross Profit
C$ -845.17KC$ 887.44KC$ 454.10KC$ 75.78KC$ -303.00
Operating Expenses
C$ 1.31MC$ 1.53MC$ 1.22MC$ 1.06MC$ 2.51M
Depreciation and Amortization
C$ 117.05KC$ 70.21KC$ 52.77KC$ 12.13KC$ 303.00
EBITDA
C$ -2.07MC$ -573.36KC$ -710.18KC$ -973.45KC$ -2.51M
Operating Income
C$ -2.15MC$ -643.57KC$ -762.95KC$ -985.58KC$ -2.51M
Other Income/Expenses
C$ -22.02KC$ -180.03KC$ -16.86KC$ 0.00C$ 0.00
Pretax Income
C$ -2.18MC$ -823.60KC$ -779.81KC$ -985.58KC$ -2.51M
Net Income
C$ -2.18MC$ -823.60KC$ -779.81KC$ -985.58KC$ -2.51M
Per Share Metrics
Basic EPS
C$ -0.02C$ -0.01C$ -0.01C$ -0.01C$ -0.03
Diluted EPS
C$ -0.02C$ -0.01C$ -0.01C$ -0.01C$ -0.03
Weighted Average Shares Outstanding
 99.58M 88.57M 84.53M 83.00M 83.00M
Weighted Average Shares Outstanding (Diluted)
 99.58M 88.57M 84.53M 83.00M 83.00M
Currency in CAD

PharmAla Biotech Holdings, Inc. Earnings and Revenue History